Relapse of Hodgkin lymphoma after autologous transplantation: Time to rethink treatment?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology,General Medicine
Reference49 articles.
1. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma;Satwani;Bone Marrow Transplant,2015
2. Simplified validated prognostic model for progression-free survival after autologous transplantation for Hodgkin lymphoma;Hahn;Biol Blood Marrow Transplant,2013
3. Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation;Martínez;Ann Oncol,2013
4. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin’s lymphoma at risk of relapse or progression (AETHERA): a randomized, double-blind, placebo-controlled, phase 3 trial;Moskowitz;Lancet,2015
5. Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group;Baetz;Ann Oncol,2003
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Classical Hodgkin’s Lymphoma;The EBMT Handbook;2024
2. Response to ifosfamide, carboplatin, etoposide (ICE) vs. dexamethasone, cytarabine cisplatin (DHAP) as salvage chemotherapy in patients with relapsed/refractory lymphoma;Annals of Medicine & Surgery;2023-07-26
3. Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group;HemaSphere;2020-01-10
4. Classical Hodgkin’s Lymphoma;The EBMT Handbook;2018-12-13
5. A role for surgery in the treatment of relapsed Hodgkin lymphoma;Pediatric Blood & Cancer;2018-10-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3